March 19, 2009 - SenoRx Inc. said today it is entering the China market, including marketing its EnCor vacuum-assisted breast biopsy product and its GelMark line of breast biopsy tissue markers through its distribution partner, Beijing Eastwide Medical Ltd. (BJEW).
SenoRx has been steadily increasing its participation in selected international markets through a strategy of partnering with local in-country distributors who have breast imaging and/or interventional radiology franchises. BJEW is a major medical instrument and equipment distribution company in China focused on women's healthcare.
"We are excited to enter the China market, which represents a continuation of our efforts to expand our international footprint in key markets where breast-care is increasingly becoming a national healthcare priority," said Lloyd Malchow, SenoRx president and CEO.
EnCor and SenoRx breast tissue biopsy markers have previously received regulatory clearances from China's State Food & Drug Administration (SFDA) and from countries within the European Economic Community and from all other countries that SenoRx has established distribution channels.
For more information: www.senorx.com
February 18, 2026 
